MyAverix Finance
US · Healthcare
Exelixis Inc (EXEL)
Biotechnology
Exelixis Inc (EXEL) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for EXEL
Exelixis Inc (EXEL) — FAQ
What is EXEL's P/E ratio?
The price-to-earnings (P/E) ratio for Exelixis Inc (EXEL) is 18.00 (data as of 2026-03-23).
Does Exelixis Inc pay a dividend?
Dividend yield is not available in the current snapshot for Exelixis Inc (EXEL). Check the MyAverix Finance app for the latest dividend data.
What sector is Exelixis Inc in?
Exelixis Inc (EXEL) is classified in the Healthcare sector (Biotechnology industry).
What exchange is EXEL listed on?
EXEL is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.